YKL-39 (chitinase 3-like protein 2), but not YKL-40 (chitinase 3-like protein 1), is up regulated in osteoarthritic chondrocytes

Annals of the Rheumatic Diseases

Volumn 62, Issue 10, 2003, Pages 995-998

  Knorr, T ^a   Obermayr, F ^b   Bartnik, E ^c   Zien, A ^d   Aigner, T ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b GPC Biotech   (Germany)

^c SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

^d FRAUNHOFER INSTITUTE FOR ALGORITHMS AND SCIENTIFIC COMPUTING SCAI   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CHITINASE 3 LIKE PROTEIN 1; CHITINASE 3 LIKE PROTEIN 2; COMPLEMENTARY DNA; INTERLEUKIN 1BETA; MESSENGER RNA; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CARTILAGE CELL; CARTILAGE DEGENERATION; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; HUMAN; IN VITRO STUDY; MOLECULE; ONLINE ANALYSIS; OSTEOARTHRITIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; RHEUMATOID ARTHRITIS; SAMPLING; SERUM; SYNOVIAL FLUID; UPREGULATION;

ADULT; AGED; AGED, 80 AND OVER; CARTILAGE, ARTICULAR; CASE-CONTROL STUDIES; CHONDROCYTES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLYCOPROTEINS; HUMANS; INTERLEUKIN-1; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OSTEOARTHRITIS; POLYMERASE CHAIN REACTION; RNA, MESSENGER; UP-REGULATION;

EID: 0041938636     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.62.10.995     Document Type: Article

References (17)

1. Hakala BE, White C, Recklies AD Human cartilage gp-39, a major secretory product of articular chondrocytes and synovial cells, is a mammalian member of a chitinase protein family. J Biol Chem 1993;268:25803-10.
2. Hu B, Trinh K, Figueira F, Price PA. Isolation and sequence of a novel human chondrocyte protein related to mammalian members of the chitinase protein family. J Biol Chem 1993;271:19415-20.
3. Johansen JS, Hvolris J, Hansen M, Backer V, Lorenzen I, Price PA. Serum ykl-40 levers in healthy children and adults. Comparison with serum and synovial fluid levels of ykl-40 in patients with osteoarthritis or trauma of the knee joint. Br J Rheumatol 1996;35:553-9.
4. Conrozier T, Carlier MC, Mathieu P, Colson F, Debard AL, Richard S, et al. Serum levers of YKL-40 and C reactive protein in patients with hip osteoarthritis and healthy subjects: a cross sectional study. Ann Rheum Dis 2000;59:828-31.
5. Kawasaki M, Hasegawa Y, Kondo S, Iwata H. Concentration and localization of YKL-40 in hip joint diseases. J Rheumatol. 2001;28:341-5.
6. Morgante M, Metelli MR, Morgante D. Observations on the increased serum levels of glycoprotein YKL-40 in patients with rheumatoid arthritis and osteoarthritis. Minerva Med 2001;92:151-3
7. Connor JR, Dodds RA, Emery JG, Kirkpatrick RB, Rosenberg M, Gowen M. Human articular cartilage glycoprotein 39 (HC gp-39) mRNA expression in adult and fetal chondrocytes, osteoblysts and osteocytes by in situ hybridization. Osteoarthritis Cartilage 2000;8:87-95.
8. Volck B, Johansen JS, Stoltenberg M, Garbarsch C, Price PA, Ostergaard M, et al. Studies on YKL-40 in knee joints of patients with rheumatoid arthritis and osteoarthritis. Involvement of YKL-40 in the joint pathology. Osteoarthritis Cartilage 2001;9:203-14.
9. Volck B, Ostergaard K, Johansen JS, Garbarch C, Price PA. The distribution of YKL-40 in osteoarthritic and normal human articular cartilage. Scand J Rheumatol 1999;28:171-9.
10. Aigner T, Zien A, Gehrsitz A, Gebhard PM, McKenna LA. Anabolic and catabolic gene expression pattern analysis in normal versus osteoarthritic cartilage using complementary DNA-array technology. Arthritis Rheum 2001;44:2777-89.
11. Tsuruha J, Masuko-Hongo K, Kato T, Sakata M, Nakamura H, Sekine T, et al. Autoimmunity against YKL-39, a human cartilage derived protein, in patients with osteoarthritis. J Rheumatol 2002;29:1459-66.
12. Bau B, Gebhard PM, Haag J, Knorr T, Bartnik E, Aigner T. Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro. Arthritis Rheum 2002;46:2648-57.
13. McKenna LA, Gehrsitz A, Soeder S, Eger W, Kirchner T, Aigner T. Effective isolation of high quality total RNA from human adult articular cartilage. Anal Biochem 2000;286:80-5.
14. De Ceuninck F, Gaufillier S, Bonnaud A, Sabatini M, Lesur C, Pastoureau P. YKL-40 (cartilage gp-39) induces proliferative events in cultured chondrocytes and synoviocytes and increases glycosaminoglycan synthesis in chondrocytes. Biochem Biophys Res Commun 2001;285:926-31.
15. Oehler S, Neureiter D, Meyer-Scholten C, Aigner T. Subtyping of osteoarthritic synoviopathy. Clin Exp Rheumatol 2002;20:633-640.
16. Aigner T, Hemmel M, Neureiter D, Gebhard PM, Zeiler G, Kirchner T, et al. Apoptotic cell death is not a widespread phenomenon in normal aging and osteoarthritic human articular knee cartilage: a study of proliferation, programmed cell death (apoptosis), and viability of chondrocytes in normal and osteoarthritic human knee cartilage. Arthritis Rheum 2001;44:1304-12.
17. Johansen JS, Olee T, Price PA, Hashimoto S, Ochs RL, Lotz M. Regulation of YKb40 production by human articular chondrocytes. Arthritis Rheum 2001;44:826-37.